StageZero Life Sciences Ltd T.SZLS

Q1 Launch update on Twitter and LinkedIn

[LithLover]

I totally missed this posted on LinkedIn and Twitter. Posted 9 hours ago. 

StageZero Life Sciences’ Aristotle 10 in 1 cancer screening test looks set to launch in Q1 2021

 

https://ow.ly/41ae50COzMJ

and than they added the investorintel link article.

no way they would be posting that on Social media if it wasn't close to launch. 

[LithLover]

Another interesting point.   So we have Stagezero making a post yesterday that Aristotle is coming in Q1 (3 months away).  Given the delays and over promises you wouldn't expect that unless it was going to happen and we know the company just received over $7 million in funding.  But here's another good sign Who likes the post on LinkedIn. Mr Harry Glorikian our

[Saaweeeetdreams]

Launching a product isnt the issue, launching a product with people lined up to buy it is...... so my point is have deals signed and ready to go. Launch it with a contract signed with a hospital, insurance company etc.....Launching a product in a vaccum wont work, if a tree falls in the forest does it make a sound, launching a product with nobody ready to buy is the same thing. Launch in Q1 is

[frewil11]

I agree 100% , I am crossing my fingers that we get some news and updates about deals being signed and the ones where the test is paid for by a insurance company for example , this in my opinion is what has to happen for Aristotle to succeed .

[capebretongirl]

Thats about it. Lets face it, with all the speculation and hundreds of posts here prior to Q3 NR and the CC, it was expected that we would be over a buck - I certainly thought so as well.  Now we know that Covid news will not really boost this stock as its considered to be a short term phenomena by investors - its all about the heart of this company which is clearly Aristotle - all the

[MarketMoney]

  Actually it's not because Covid revenu isn't taking in account, ther's simply not alot of demand for this stock at the present moment.  Covid revenu is great, in fact any good revenu is great, cashflow is important to keep the boat afloat.   One day there will be more demand for this stock :-)

[kingpine]

I think that once we get over $1.50 many investors will be interested in investing. 1:16 instead of 1:8 would have been a good idea. And the story would be different. But we're going to get there it's just going to take longer. 

[MarketMoney]

  I'm more interested at a above 5 CAD so we could closer to NASDAQ :-)   

[capebretongirl]

Yes, when you look at various climbers this past week like SPOR, NUMI, TRIP, HIVE, DMGI, HUT etc., the volume levels were off the chart as investors climbed on board and the share prices soared. The same thing will occur here if Aristotle gets the reception we hope.